Perspective Therapeutics (FRA:AAJ0) Interest Expense : €-0.04 Mil (TTM As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Perspective Therapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Perspective Therapeutics's interest expense for the three months ended in Dec. 2024 was € 0.07 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.04 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Perspective Therapeutics's Operating Income for the three months ended in Dec. 2024 was € -19.96 Mil. Perspective Therapeutics's Interest Expense for the three months ended in Dec. 2024 was € 0.07 Mil. Perspective Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Perspective Therapeutics Interest Expense Historical Data

The historical data trend for Perspective Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perspective Therapeutics Interest Expense Chart

Perspective Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-0.08

-0.05

Perspective Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-0.02	-0.03	-0.02	-0.06	0.07

Perspective Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.04 Mil.

Perspective Therapeutics (FRA:AAJ0) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Perspective Therapeutics's Interest Expense for the three months ended in Dec. 2024 was €0.07 Mil. Its Operating Income for the three months ended in Dec. 2024 was €-19.96 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was €2.92 Mil.

Perspective Therapeutics's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

The higher the ratio, the stronger the company's financial strength is.

Perspective Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Perspective Therapeutics Inc (FRA:AAJ0) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

CATX:USA AAJ0:Germany

Address

2401 Elliott Avenue, Suite 320, Seattle, WA, USA, 98121

Website

https://www.perspectivetherapeutics.com

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Perspective Therapeutics Headlines

No Headlines